In summary, the elucidation of YAP/TAZ-mediated molecular mechanisms and their intricate involvement in liver pathophysiology not only enhances our understanding of liver diseases but also paves the way for the development of innovative therapeutic strategies aimed at addressing unmet clinical needs in the field of hepatology. The gene discussed is YAP1; the disease is liver disorder.